Joint Symposium combines expertise from Europe, US

0623-Joint Symposium

Attend the EADV/AAD Joint Symposium from 9 a.m. to noon Thursday, July 28.

Expert dermatologists from Europe and the United States will share how they approach a range of dermatologic conditions and their treatments when the European Academy of Dermatology and Venereology (EADV) and the AAD present the “EADV/AAD Joint Symposium.” From an American dermatologist examining dermatomyositis to a Spanish dermatologist discussing the influence of genes on melanoma phenotypes, speakers will explore developments from their regions of the world.

“We selected topics where expert presenters from one continent often have more experience than those from the other continent, and vice versa,” said Jean L. Bolognia, MD, professor of dermatology at the Yale School of Medicine, New Haven, Connecticut.

Topics and presenters from America will be:

  • “Clinical Pearls for the Diagnosis and Management of Dermatomyositis” by Ruth Ann Vleugels, MD, MPH, associate professor of dermatology at Harvard Medical School, Boston
  • “Recent Advances in Laser, Light, and Energy-Based Therapies” by Jeffrey S. Dover, MD, co-director of SkinCare Physicians, Chestnut Hill, Massachusetts

From the other side of the pond, topics will be:

  • “Genotype-Phenotype Correlation for Patients With Melanoma or at Risk for Melanoma” by Susana Puig, MD, director of the research program of the melanoma unit at the University Hospital Clinic of Barcelona, Spain
  • “Common Genodermatoses: Ones You Do Not Want to Miss” by Eli Sprecher, MD, PhD, director of dermatology at Tel-Aviv Sourasky Medical Center, Israel
  • “Neurofibromatosis Type I” by Pierre Wolkenstein, MD, PhD, professor of dermatology at Henri-Mondor Hospital-University of Paris-Est Créteil, France

Dr. Bolognia said planners sought to offer presentations that spanned the spectrum of dermatology, noting that the symposium is aimed at dermatologists who care for both children and adults, and who practice medical as well as some surgical dermatology.

“We’ll move from genodermatoses and genotype-phenotype correlations, which involve translational medicine, all the way to lasers,” Dr. Bolognia said. “It is obvious that a dermatologist taking care of children needs to know about genodermatoses, and when examining adults, insights into melanoma phenotypes are important. However, patients also expect their dermatologist to have a working knowledge of skin-directed procedures, such as laser surgery, even if they don’t personally perform them. Hopefully, those attending the symposium will leave feeling more confident in their practice of general dermatology.”

Dr. Bolognia and Martin Röcken, MD, medical director of the department of dermatology at the University of Tuebingen, Germany, are co-directors of the symposium, which will be presented from 9 a.m. to noon Thursday, July 28. Each year, this symposium is held at both the AAD Summer Meeting and the fall EADV Congress.

Return to Index

Top